Searched for
RECOMBINANT PROTEIN VACCINE
IIT Guwahati completes technology transfer to BioMed for first recombinant vaccine for Swine Fever VirusIndian Institute of Technology Guwahati transferred a pioneering vaccine technology to BioMed Pvt. Ltd. for a recombinant vector vaccine co...- Enhanced recombination: A shot in the arm for SARS-CoV-2The team analysed genomic sequences of all the viral strains that appeared between November 2019 and July 2022 in various databases worldwi...
- Covid-19 Omicron XE: What does 'recombinant' mean and how fast does this variant spread?XE has also been identified in India, China and Thailand.
- What's the new Omicron XE variant and should I be worried?A "recombinant" variant has emerged, dubbed "Omicron XE", which is the result of two omicron strains merging together in a single host and ...
- DCGI gives nod to SII's proposal to manufacture vaccine against omicron for test, analysis"Development of this vaccine shall be another example of vaccine production strength of our country in line with the clarion call of our pr...
- SII set to export 25 crore Covovax doses for Covax from next monthIndia's drug regulator had on December 28 granted emergency use authorisation (EUA) to Covovax. However, with the government not planning t...
- View: India needs to act fast to avoid flying blind into Omicron and beyondBooster doses will become available in India from January 10. The prioritisation and sequence of administration would be based on completin...
- Sanofi drops plans for messenger RNA vaccine against virusThe Paris-based company said it will continue to develop another vaccine candidate that is already undergoing late stage human trials. That...
- Reliance Life gets regulatory nod for trials of 2-dose vaccineThe drug regulatory authority on Thursday approved Reliance Life Sciences, part of India's largest private sector enterprise-application, s...
- Sanofi, GSK receive nod for Phase 3 trial of COVID-19 vaccine candidate in IndiaThe design of the Phase 3 study, conducted across a broad diversity of geographies, also allows evaluation of the efficacy of the candidate...
- Novavax and the recombinant protein vaccine: What you need to knowThe recombinant protein vaccine develops the body’s immunity against the coronavirus by using the virus' spike proteins. Used by Novavax in...
- China approves 16 locally-made COVID-19 vaccines for clinical trialsChina has already given conditional approval to two inactivated COVID-19 vaccines made by state-owned developers -- Sinopharm and Sinovac B...
- CEPI labs to help improve Covid-19 vaccine evaluationThe initiative, led by the not for profit Coalition of Epidemic Preparedness and Innovation (CEPI), is looking to bring in as many global v...
- Russian vaccine safe, induces antibody response in small human trials: Lancet StudyResults from early-phase non-randomised vaccine trials in a total of 76 people show that two formulations of the vaccine have a good safety...
- ‘Globally, companies can produce 2-4 billion Covid vaccine doses by 2021 end’The study was carried out between April 3 and June 19 to assess potential bottlenecks in manufacturing the vaccine and the global capacity ...
- US company trials coronavirus vaccine candidate in AustraliaNovavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and looking for signs of its effective...
- This smallcap firm to work on Covid-19 vaccine; shares rally 20%Indian Institute of Technology Guwahati and Hester Biosciences expect the vaccine to be ready by the end of this year.
- GSK, Sanofi team up to bring out Covid-19 vaccineTwo of the world's largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a Covid-19 vaccine, which if i...
- Sanofi joins hands with US govt to expedite development of coronavirus vaccineAs part of the initiative, the company said it will collaborate with Biomedical Advanced Research and Development Authority (BARDA) of the ...
- New vaccine may fight both tuberculosis and leprosyScientists have found that a variant of an existing vaccine offers stronger protection against both tuberculosis and leprosy.
Load More
